PRECIGEN, INC. - Common Stock (PGEN) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
PGEN on Nasdaq
Shares outstanding
353,007,843
Price per share
$4.53
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
135,990,884
Total reported value
$568,456,741
% of total 13F portfolios
0%
Share change
+22,252,534
Value change
+$96,338,541
Number of holders
176
Price from insider filings
$4.53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PRECIGEN, INC. - Common Stock (PGEN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Patient Capital Management, LLC 10% -24% $150,508,424 -$38,525,651 36,006,800 -20% Patient Capital Management, LLC 31 Dec 2025
Miller William H III 9.2% $154,936,259 34,051,925 William H. Miller III Living Trust dated April 17, 2017 26 Jun 2025
Point72 Asset Management, L.P. 5.2% $76,841,952 18,383,242 Point72 Asset Management, L.P. 22 Jan 2026

As of 31 Dec 2025, 176 institutional investors reported holding 135,990,884 shares of PRECIGEN, INC. - Common Stock (PGEN). This represents 39% of the company’s total 353,007,843 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of PRECIGEN, INC. - Common Stock (PGEN) together control 34% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Patient Capital Management, LLC 5.3% 18,673,466 -29% 3% $78,055,089
BlackRock, Inc. 4.3% 15,094,359 +24% 0% $63,094,420
Point72 Asset Management, L.P. 3.9% 13,724,141 +401% 0.09% $57,366,909
STATE STREET CORP 3.1% 10,824,860 +141% 0% $45,247,915
VANGUARD GROUP INC 3% 10,479,452 +17% 0% $43,804,109
TANG CAPITAL MANAGEMENT LLC 1.6% 5,617,500 -55% 1.2% $23,481,150
FMR LLC 1.3% 4,652,179 +3888% 0% $19,446,108
GEODE CAPITAL MANAGEMENT, LLC 1.3% 4,462,078 +16% 0% $18,653,479
Diametric Capital, LP 1.1% 3,847,024 +295% 4.3% $16,080,560
Driehaus Capital Management LLC 1% 3,601,674 +76% 0.1% $15,054,997
IRIDIAN ASSET MANAGEMENT LLC/CT 1% 3,600,195 -1.8% 5.5% $15,048,815
Occam Crest Management LP 0.99% 3,501,739 +30% 10% $14,637,269
CITADEL ADVISORS LLC 0.92% 3,249,684 +21% 0.01% $13,583,679
MORGAN STANLEY 0.9% 3,193,522 +61% 0% $13,348,922
SymBiosis Capital Partners, LLC 0.85% 3,000,000 0% 13% $12,540,000
BANK OF AMERICA CORP /DE/ 0.62% 2,188,606 -13% 0% $9,148,372
GOLDMAN SACHS GROUP INC 0.62% 2,173,933 +196% 0% $9,087,040
NORTHERN TRUST CORP 0.45% 1,579,142 +15% 0% $6,600,813
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.43% 1,506,755 +20% 0% $6,298,236
Woodline Partners LP 0.4% 1,400,961 0.02% $5,856,017
Boxer Capital Management, LLC 0.39% 1,375,000 +62% 1.3% $5,747,500
Parkman Healthcare Partners LLC 0.28% 1,002,826 -52% 0.4% $4,191,813
JPMORGAN CHASE & CO 0.26% 914,919 +20% 0% $3,824,362
UBS Group AG 0.25% 891,428 +41% 0% $3,726,169
BARCLAYS PLC 0.25% 865,378 +56% 0% $3,617,281

Institutional Holders of PRECIGEN, INC. - Common Stock (PGEN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 135,990,884 $568,456,741 +$96,338,541 $4.18 176
2025 Q3 111,297,177 $366,220,521 +$89,540,549 $3.29 165
2025 Q2 82,070,744 $116,553,437 +$2,653,090 $1.42 146
2025 Q1 80,161,429 $119,337,253 +$7,804,799 $1.49 137
2024 Q4 75,787,342 $84,752,627 +$1,018,038 $1.12 130
2024 Q3 74,934,960 $70,966,781 +$13,973,301 $0.95 123
2024 Q2 60,722,436 $95,930,395 -$1,354,697 $1.58 130
2024 Q1 61,605,921 $89,315,893 -$1,244,521 $1.45 127
2023 Q4 62,597,104 $83,879,140 +$2,482,228 $1.34 136
2023 Q3 60,552,257 $85,976,957 +$4,927,378 $1.42 135
2023 Q2 57,391,361 $65,981,492 -$3,631,686 $1.15 137
2023 Q1 61,459,047 $65,137,179 +$19,788,601 $1.06 155
2022 Q4 42,284,714 $64,263,385 -$330,510 $1.52 157
2022 Q3 125,018,911 $265,021,859 -$18,455,826 $2.12 151
2022 Q2 135,952,580 $182,176,824 -$10,848,844 $1.34 154
2022 Q1 143,469,817 $302,712,530 +$212,819 $2.11 159
2021 Q4 142,860,197 $529,867,886 +$12,686,695 $3.71 157
2021 Q3 138,272,261 $690,254,065 -$19,066,872 $4.99 162
2021 Q2 142,052,644 $926,165,482 -$505,170 $6.52 142
2021 Q1 142,033,611 $978,581,859 +$140,930,422 $6.89 154
2020 Q4 121,129,113 $1,235,480,007 -$19,579,424 $10.20 142
2020 Q3 123,718,445 $433,031,361 +$6,466,151 $3.50 145
2020 Q2 121,163,398 $604,513,971 -$28,168,416 $4.99 134
2020 Q1 129,153,759 $439,106,078 +$437,977,926 $3.40 134
2019 Q4 227,607 $1,148,000 +$636,000 $5.48 4
2019 Q3 42,862 $279,000 $6.51 1
2019 Q2 42,862 $279,000 $6.51 1
2019 Q1 42,862 $279,000 $6.51 1
2016 Q2 0 $0 -$12,709 $4.53 0
2016 Q1 375 $12,709 $33.89 1